The Rosen Law Firm Announces Investigation of Roka Bioscience, Inc. – ROKA
23 December 2014 - 4:01AM
Business Wire
The Rosen Law Firm announces that it is investigating potential
securities claim against Roka Bioscience, Inc. (“Roka”, or the
“Company”) (NASDAQ: ROKA) resulting from allegations that the
Company may have failed to disclosed known trends and
uncertainties.
Roka derives its revenues from selling Atlas diagnostic
instruments and proprietary Atlas Detection Assays for use in the
instruments. Roka’s revenues depends crucially on the number of
Atlas diagnostic instruments it has been able to install. Roka is
at an early stage of commercialization.
Roka conducted its Initial Public Offering (“IPO”) on July 17,
2014, boasting that it had installed 36 Atlas instruments, selling
its shares at $12 each. But on November 6, 2014, Atlas announced a
surprise loss of ($0.64) per share in the third quarter of 2014.
Atlas also admitted that it had not placed any Atlas instruments in
that quarter. That day, Roka’s stock price fell from $8.34 to
$3.00, damaging investors.
The Rosen Law Firm is investigating a securities class action
lawsuit on behalf of Roka investors. If you purchased Roka stock
before November 7, 2014, please visit the website at
http://rosenlegal.com for more information. You may also contact
Jonathan Horne, Esq., or Phillip Kim, Esq. of The Rosen Law Firm
toll free at 866-767-3653 or via e-mail at jhorne@rosenlegal.com or
pkim@rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
The Rosen Law Firm P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Jonathan Horne, Esq.275 Madison Avenue 34th FloorNew York, New
York 10016Tel: 212-686-1060Weekend Tel: 917-562-8616Toll Free:
1-866-767-3653Fax:
212-202-3827lrosen@rosenlegal.comjhorne@rosenlegal.compkim@rosenlegal.comwww.rosenlegal.com
ROKA BIOSCIENCE, INC. (NASDAQ:ROKA)
Historical Stock Chart
From Apr 2024 to May 2024
ROKA BIOSCIENCE, INC. (NASDAQ:ROKA)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Sorrento Tech Com USD0.001 (MM) (NASDAQ): 0 recent articles
More Roka Bioscience, Inc. (MM) News Articles